2136 related articles for article (PubMed ID: 26658811)
21. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
Kuerten S; Pauly R; Rottlaender A; Rodi M; Gruppe TL; Addicks K; Tary-Lehmann M; Lehmann PV
Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
[TBL] [Abstract][Full Text] [Related]
22. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
[TBL] [Abstract][Full Text] [Related]
23. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
24. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
26. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
27. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.
Kuerten S; Javeri S; Tary-Lehmann M; Lehmann PV; Angelov DN
Clin Immunol; 2008 Nov; 129(2):256-67. PubMed ID: 18722816
[TBL] [Abstract][Full Text] [Related]
28. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
[TBL] [Abstract][Full Text] [Related]
29. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
[TBL] [Abstract][Full Text] [Related]
30. Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein.
Chalk JB; McCombe PA; Pender MP
Brain; 1994 Oct; 117 ( Pt 5)():975-86. PubMed ID: 7525006
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein.
Castoldi V; Marenna S; d'Isa R; Huang SC; De Battista D; Chirizzi C; Chaabane L; Kumar D; Boschert U; Comi G; Leocani L
Brain Pathol; 2020 Jan; 30(1):137-150. PubMed ID: 31267597
[TBL] [Abstract][Full Text] [Related]
32. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
33. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
34. Contribution of LTi and T
Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S
J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214
[TBL] [Abstract][Full Text] [Related]
35. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
37. Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain.
Takano C; Takano T; Masumura M; Nakamura R; Koda S; Bochimoto H; Yoshida S; Bando Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175866
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
39. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
40. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
